<DOC>
	<DOCNO>NCT03020329</DOCNO>
	<brief_summary>1 . To see effect combination induction chemotherapy follow chemoradiotherapy work treat child advance nasopharyngeal carcinoma ( NPC ) .</brief_summary>
	<brief_title>Induction Chemotherapy Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma</brief_title>
	<detailed_description>This phase II trial study well radiation therapy chemotherapy work treat young patient newly diagnose nasopharyngeal cancer . Radiation therapy use high-energy x-ray kill tumor cell . Drugs use chemotherapy , cisplatin fluorouracil paclitaxel , work different way stop growth tumor cell , either kill cell stop dividing .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Patients newly histologically confirm nonkeratinizing ( accord World Health Organization ( WHO ) histologically type ) . Original clinical stag T4N03 M0 T、N3M0（according American Joint Committee Cancer ( AJCC ) 7th edition） No evidence distant metastasis ( M0 ) . Age ≤ 18 year old . Satisfactory performance status : Karnofsky scale ( KPS ) &gt; 70 . Adequate marrow : leucocyte count ≥4000/μL , hemoglobin ≥90g/L platelet count ≥100000/μL . Normal liver function test : Alanine Aminotransferase ( ALT ) 、Aspartate Aminotransferase ( AST ) &lt; 1.5×upper limit normal ( ULN ) concomitant alkaline phosphatase ( ALP ) ≤2.5×ULN , bilirubin ≤ULN . Adequate renal function : creatinine clearance ≥60 ml/min . Patients must inform investigational nature study give write informed consent . WHO Type keratinize squamous cell carcinoma basaloid squamous cell carcinoma . Age &gt; 18 year . Treatment palliative intent . Prior malignancy except adequately treat basal cell squamous cell skin cancer , situ cervical cancer . Pregnancy lactation . History previous radiotherapy ( except nonmelanomatous skin cancer outside intend RT treatment volume ) . Prior chemotherapy surgery ( except diagnostic ) primary tumor node . Any severe intercurrent disease , may bring unacceptable risk affect compliance trial , example , unstable cardiac disease require treatment , renal disease , chronic hepatitis , diabetes poor control ( fast plasma glucose &gt; 1.5×ULN ) , emotional disturbance .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Induction Chemotherapy</keyword>
	<keyword>Nasopharyngeal carcinoma</keyword>
	<keyword>Chemoradiotherapy</keyword>
</DOC>